<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31354" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>White Dot Syndromes</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mount</surname>
            <given-names>George R.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaufman</surname>
            <given-names>Evan J.</given-names>
          </name>
          <aff>University of Virginia Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>George Mount declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Evan Kaufman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31354.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The white dot syndromes constitute a group of inflammatory chorioretinopathies in which the common defining clinical feature is the presence of multiple, discrete, white lesions located at the deeper levels of the retina and choroid. Though several of the white dot syndromes are associated with a viral prodrome, an etiology is lacking for these conditions. Typically seen in young, otherwise healthy adults, the white dot syndromes most often present with symptoms of photopsia, floaters, decreased night vision, blurred vision, and visual field loss. In general, these conditions are acute in onset, and many, though not all, are transient without long-term visual consequence. Though the white dot syndromes share many similar clinical features, including the tell-tale chorioretinal lesions, several distinct clinical features and diagnostic testing findings allow for additional characterization. This activity outlines the white dot syndromes to include a discussion of etiologies, epidemiology, pertinent history and examination findings, options for evaluation, and the interprofessional healthcare team's role in managing patients with these conditions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the typical clinical features of the white dot syndromes.</p></list-item><list-item><p>Outline the appropriate evaluation of a patient with a presumptive white dot syndrome.</p></list-item><list-item><p>Review the management options available for white dot syndromes.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the management of white dot syndromes and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31354&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31354">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31354.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The white dot syndromes constitute a group of inflammatory chorioretinopathies. The common, defining clinical feature is the presence of multiple, discrete, white lesions located at the deeper levels of the retina choroid.<xref ref-type="bibr" rid="article-31354.r1">[1]</xref>&#x000a0;Several of the white dot syndromes are associated with a viral prodrome, and an etiology is lacking for these conditions. Typically seen in young, otherwise healthy adults, the white dot syndromes most often present with symptoms of photopsia, floaters, decreased night vision, blurred vision, and visual field loss.<xref ref-type="bibr" rid="article-31354.r2">[2]</xref>&#x000a0;These conditions can be acute in onset or transient without long-term visual consequence. White dot syndromes share many similar clinical features, including the "tell-tale" chorioretinal lesions, several distinct clinical features, and diagnostic testing findings that allow for additional characterization. Commonly recognized white dot syndromes include: Multiple evanescent white dot syndrome (MEWDS), acute retinal pigment epitheliopathy (ARPE), acute posterior multifocal placoid pigment epitheliopathy (APMPPE), multifocal choroiditis and panuveitis (MCP), acute zonal occult outer retinopathy (AZOOR), birdshot chorioretinopathy, serpiginous choroidopathy, and punctate inner choroidopathy (PIC).<xref ref-type="bibr" rid="article-31354.r1">[1]</xref>&#x000a0;These conditions are conventionally recognized as distinct identities, and some suggest that they represent a spectrum of chorioretinal disease.<xref ref-type="bibr" rid="article-31354.r3">[3]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31354.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of the white dot syndromes remains unknown. Several entities are associated with a viral prodrome, suggesting a potential viral or infectious etiology. Similar to most autoimmune conditions, an unknown trigger is thought to precipitate an inflammatory or autoimmune process in the posterior eye.<xref ref-type="bibr" rid="article-31354.r4">[4]</xref>&#x000a0;The white dot syndromes represent a primary ocular process and are not associated with systemic inflammatory or autoimmune disease. An increased prevalence of such conditions has been demonstrated in several subgroups of patients with white dot syndrome (i.e., AZOOR).<xref ref-type="bibr" rid="article-31354.r5">[5]</xref>&#x000a0;Birdshot chorioretinopathy is highly associated with the presence of the HLA-A29 haplotype.<xref ref-type="bibr" rid="article-31354.r6">[6]</xref>&#x000a0;This correlation is so prominent that the absence of this haplotype, even within the presence of typical clinical features, should prompt consideration of an alternative diagnosis.</p>
      </sec>
      <sec id="article-31354.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>With a few exceptions (birdshot chorioretinopathy, serpiginous choroiditis), white dot syndromes present in young, otherwise healthy, adults below the age of 50.<xref ref-type="bibr" rid="article-31354.r1">[1]</xref>&#x000a0;Gender differences allow for further characterization of these entities, with a female predominance recognized in birdshot chorioretinopathy, MCP, PIC, AZOOR, and MEWDS.<xref ref-type="bibr" rid="article-31354.r2">[2]</xref>&#x000a0;The incidence of white dot syndromes in a community-based population was 0.45 per 100,000 per year, consistent with their description as rare disease entities.<xref ref-type="bibr" rid="article-31354.r7">[7]</xref></p>
      </sec>
      <sec id="article-31354.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Historical features most consistent with a white dot syndrome include the relatively acute onset of visual symptoms, including visual field loss or scotoma, flashes of light or photopsia, blurred vision, and floaters.<xref ref-type="bibr" rid="article-31354.r2">[2]</xref>&#x000a0;Consistent with a potential viral or infectious etiology, patients may report symptoms of a viral prodrome. The primary feature involves developing characteristic white or cream-colored chorioretinal lesions, the morphology and distribution of which aid in distinguishing white dot syndrome from others. White dot syndromes may differ in the laterality of involvement, with some conditions typically presenting in a unilateral fashion (MEWDS), others are bilateral (APMPPE, birdshot chorioretinopathy, MCP).<xref ref-type="bibr" rid="article-31354.r1">[1]</xref>&#x000a0;The presence of anterior chamber cell or inflammation is rare, except for MCP. Vitritis may be seen in several white dot syndromes; it is most consistently seen in birdshot chorioretinopathy.<xref ref-type="bibr" rid="article-31354.r8">[8]</xref></p>
      </sec>
      <sec id="article-31354.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory testing in patients with a white dot syndrome is generally most useful in excluding alternative etiologies on the differential diagnosis.<xref ref-type="bibr" rid="article-31354.r9">[9]</xref><xref ref-type="bibr" rid="article-31354.r10">[10]</xref><xref ref-type="bibr" rid="article-31354.r11">[11]</xref>&#x000a0;Serologic testing for syphilis is recommended in all patients, with screening for tuberculosis conducted in those patients with known exposure or risks. A poor screening test, angiotensin-converting enzyme (ACE) levels are often obtained in conjunction with chest x-ray imaging to evaluate for evidence of underlying sarcoidosis.<xref ref-type="bibr" rid="article-31354.r12">[12]</xref>&#x000a0;Ocular diagnostic testing may assist in the differentiation of specific white dot syndromes with suggestive features often evident on fluorescein angiography (FA), optical coherence tomography (OCT), visual field testing, indocyanine green (ICG) angiography, fundus autofluorescence, and electroretinography (ERG) studies.<xref ref-type="bibr" rid="article-31354.r13">[13]</xref><xref ref-type="bibr" rid="article-31354.r14">[14]</xref><xref ref-type="bibr" rid="article-31354.r15">[15]</xref><xref ref-type="bibr" rid="article-31354.r16">[16]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-31354.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Many of the white dot syndromes are benign and self-limited, negating the need for treatment. A few white dot syndromes are persistent and progressive, with significant visual consequences if untreated (MCP, serpiginous choroiditis, and birdshot chorioretinopathy). Treatment in these conditions initially involves using local or systemic corticosteroids with a transition to steroid-sparing systemic immunotherapy.<xref ref-type="bibr" rid="article-31354.r17">[17]</xref><xref ref-type="bibr" rid="article-31354.r18">[18]</xref>&#x000a0;Typical agents would include traditional immunotherapies such as methotrexate, mycophenolate mofetil, azathioprine, cyclosporine, as well as biological agents, including anti-TNF medications: adalimumab and infliximab.<xref ref-type="bibr" rid="article-31354.r19">[19]</xref>&#x000a0;In vision-threatening conditions such as serpiginous choroiditis, the cytotoxic agents cyclophosphamide and chlorambucil have been utilized.<xref ref-type="bibr" rid="article-31354.r20">[20]</xref>&#x000a0;Management of associated ocular complications such as cystoid macular edema (CME) and choroidal neovascularization (CNV) may involve immunosuppression or localized ocular therapies to include anti-vascular endothelial growth factor (VEGF) agents, laser photocoagulation therapy, or photodynamic therapy.<xref ref-type="bibr" rid="article-31354.r21">[21]</xref><xref ref-type="bibr" rid="article-31354.r22">[22]</xref><xref ref-type="bibr" rid="article-31354.r23">[23]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31354.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Both infectious and noninfectious entities are included in the differential diagnosis of the white dot syndromes. The noninfectious processes include sarcoidosis, Vogt-Koyanagi-Harada (VKH) syndrome, sympathetic ophthalmia, and intraocular lymphoma.<xref ref-type="bibr" rid="article-31354.r11">[11]</xref>&#x000a0;Syphilis, primary ocular histoplasmosis syndrome (POHS), tuberculosis, and diffuse unilateral subacute neuroretinitis (DUSN) are infectious entities that should be considered in the differential diagnosis of white dot syndrome.<xref ref-type="bibr" rid="article-31354.r24">[24]</xref></p>
      </sec>
      <sec id="article-31354.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for most white dot syndromes (ARPE, MEWDS, APMPPE, AZOOR) is good, with most patients experiencing a benign and self-limited course with an eventual return to or near baseline vision.<xref ref-type="bibr" rid="article-31354.r25">[25]</xref><xref ref-type="bibr" rid="article-31354.r26">[26]</xref><xref ref-type="bibr" rid="article-31354.r27">[27]</xref><xref ref-type="bibr" rid="article-31354.r26">[26]</xref>&#x000a0;The persistence of various visual phenomena, such as scotoma and photopsia, may occur in a small percentage of such patients.<xref ref-type="bibr" rid="article-31354.r26">[26]</xref>&#x000a0;Several white dot syndromes (MCP, birdshot chorioretinopathy, serpiginous choroiditis) demonstrate a more persistent and progressive clinical course and may result in moderate to severe visual decrement.<xref ref-type="bibr" rid="article-31354.r28">[28]</xref><xref ref-type="bibr" rid="article-31354.r29">[29]</xref><xref ref-type="bibr" rid="article-31354.r30">[30]</xref><xref ref-type="bibr" rid="article-31354.r28">[28]</xref>&#x000a0;Early identification and management of these conditions are, therefore, of paramount importance.</p>
      </sec>
      <sec id="article-31354.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Extraocular complications of white dot syndromes are rare. Patients may present with a viral prodrome that is typically self-limiting. In patients with APMPPE, symptoms of a viral prodrome may include meningeal features.<xref ref-type="bibr" rid="article-31354.r31">[31]</xref>&#x000a0;A few of the white dot syndromes are associated with autoimmune disease, so carefully evaluate for symptoms or signs that might suggest such a condition.<xref ref-type="bibr" rid="article-31354.r4">[4]</xref>&#x000a0;Potential complications related to the use of systemic immunotherapy require monitoring by a specialist trained in the use of such agents.<xref ref-type="bibr" rid="article-31354.r19">[19]</xref>&#x000a0;</p>
        <p>Associated ocular complications include those inherent to chorioretinopathy, such as cystoid macular edema (CME) and choroidal neovascularization (CNV). The development of choroidal neovascular membranes is a prominent complication seen in patients with PIC, with estimates of 40% to 75% in some cases series.<xref ref-type="bibr" rid="article-31354.r32">[32]</xref>&#x000a0;Ocular complications related to the use of topical, periocular, and intravitreal corticosteroids would include premature cataract formation and increased intraocular pressure, as well as those related to procedural or surgical management.<xref ref-type="bibr" rid="article-31354.r33">[33]</xref><xref ref-type="bibr" rid="article-31354.r34">[34]</xref></p>
      </sec>
      <sec id="article-31354.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As stated previously, most white dot syndromes are self-limiting, and therefore no treatment is generally necessary. The clinician may want to closely monitor the condition for a month&#x000a0;using dilated funduscopic examinations.</p>
      </sec>
      <sec id="article-31354.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>A detailed review of individual white dot syndromes is beyond the scope of this article. The following pearls highlight several key distinguishing clinical features of several of the white dot syndromes.<xref ref-type="bibr" rid="article-31354.r1">[1]</xref><xref ref-type="bibr" rid="article-31354.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Multiple evanescent white dot syndrome (MEWDS): young patients (age 20 to 50 years), women &#x0003e; men, often viral prodrome, typically unilateral, good visual prognosis, small white dots in the outer retina, &#x0201c;wreath-like&#x0201d; pattern of hyperfluorescence on FA<xref ref-type="bibr" rid="article-31354.r27">[27]</xref><xref ref-type="bibr" rid="article-31354.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Acute retinal pigment epitheliitis (ARPE): young patients (age 10 to 30 years), women = men, most often unilateral, small hyperpigmented lesions, excellent visual prognosis<xref ref-type="bibr" rid="article-31354.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>Acute posterior multifocal placoid pigment epitheliopathy (APMPPE): young patients (age 20 to 30 years), women = men, typically bilateral, flat gray or white placoid lesions at the level of the retinal pigment epithelium (RPE) and inner choroid, good visual prognosis<xref ref-type="bibr" rid="article-31354.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Acute zonal occult outer retinopathy (AZOOR): young patients, often myopic, women &#x0003e; men, typically bilateral (though asymmetric), initially normal-appearing fundus followed by zonal RPE atrophy and pigmentary changes, no clear benefit from treatment, good visual prognosis, though may progress or recur<xref ref-type="bibr" rid="article-31354.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>Multifocal choroiditis and panuveitis (MCP): young to middle-age patients (age 20 to 60 years), women &#x0003e; men, bilateral, presence of anterior chamber and vitreous inflammation along with multiple yellow-white chorioretinal lesions with subsequent atrophy and scarring, complicated by CME and CNV, poor visual prognosis, treatment generally required<xref ref-type="bibr" rid="article-31354.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Birdshot chorioretinopathy: middle-aged patients (age 40 to 60 years), women &#x0003e; men, bilateral, difficulty with night vision, multiple cream-colored lesions in a birdshot style, radiating pattern nasally predominant, associated vitritis, CME, and retinal vasculitis, highly correlated with the presence of HLA-A29, &#x0201c;quenching&#x0201d; on FA, guarded visual prognosis, treatment generally required<xref ref-type="bibr" rid="article-31354.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Serpiginous choroiditis: middle-aged patients (age 30 to 60 years), men &#x0003e; women, bilateral (asymmetric), the geographic pattern of chorioretinal scarring, guarded to poor prognosis, treatment may require alkylating agents<xref ref-type="bibr" rid="article-31354.r29">[29]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Punctate inner choroidopathy (PIC): young patients (under 40 years of age), women &#x0003e; men, bilateral, small punctate gray or yellow lesions in the posterior pole evolve to atrophic scars, absence of vitritis, associated with CNV, good visual prognosis though more guarded with the development of CNV<xref ref-type="bibr" rid="article-31354.r32">[32]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31354.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Thankfully, many white dot syndromes are self-limited and do not require treatment. Still, exceptions exist, and, in these circumstances, treatment often involves the use of systemic immunosuppressive therapy. Coordination of care between an ophthalmologist specializing in chorioretinal disease and a rheumatologist is often needed for optimal care. Consideration should be given to case conferences or joint clinics to facilitate such coordination.<xref ref-type="bibr" rid="article-31354.r38">[38]</xref>&#x000a0;An interprofessional healthcare team coordinating between the patient's family clinician, ophthalmology specialists, and nursing staff will lead to optimal results through accurate diagnosis, patient education, and in some instances, based on the particular variant, active intervention. [Level 5]</p>
        <p>The views expressed are those of the author and do not reflect the official policy of the Department of the Army, the Department of Defense, or the U.S. Government.</p>
      </sec>
      <sec id="article-31354.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31354&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31354">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/white-dot-syndromes/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31354">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31354/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31354">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31354.s15">
        <title>References</title>
        <ref id="article-31354.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quillen</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Blodi</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Callanan</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Equi</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>The white dot syndromes.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>137</volume>
            <issue>3</issue>
            <fpage>538</fpage>
            <page-range>538-50</page-range>
            <pub-id pub-id-type="pmid">15013878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crawford</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Igboeli</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>A review of the inflammatory chorioretinopathies: the white dot syndromes.</article-title>
            <source>ISRN Inflamm</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>783190</fpage>
            <pub-id pub-id-type="pmid">24294536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases?</article-title>
            <source>Am J Ophthalmol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>380</fpage>
            <page-range>380-1</page-range>
            <pub-id pub-id-type="pmid">12614758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>376</fpage>
            <page-range>376-9</page-range>
            <pub-id pub-id-type="pmid">12614757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>IU</given-names>
              </name>
            </person-group>
            <article-title>Acute zonal occult outer retinopathy: a long-term follow-up study.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-39</page-range>
            <pub-id pub-id-type="pmid">12208243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LeHoang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Benhamou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tabary</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Edelson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Betuel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Semiglia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>HLA-A29.2 subtype associated with birdshot retinochoroidopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1992</year>
            <month>Jan</month>
            <day>15</day>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-5</page-range>
            <pub-id pub-id-type="pmid">1728143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abu-Yaghi</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Hartono</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Bakri</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>White dot syndromes: a 20-year study of incidence, clinical features, and outcomes.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-30</page-range>
            <pub-id pub-id-type="pmid">22106911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Vitiliginous chorioretinitis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1981</year>
            <month>Oct</month>
            <volume>99</volume>
            <issue>10</issue>
            <fpage>1778</fpage>
            <page-range>1778-87</page-range>
            <pub-id pub-id-type="pmid">7295126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Essential laboratory tests in uveitis.</article-title>
            <source>Dev Ophthalmol</source>
            <year>1999</year>
            <volume>31</volume>
            <fpage>92</fpage>
            <page-range>92-108</page-range>
            <pub-id pub-id-type="pmid">10641202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Randhawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Van Gelder</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Patterns of Laboratory Testing Utilization Among Uveitis Specialists.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>170</volume>
            <fpage>161</fpage>
            <page-range>161-167</page-range>
            <pub-id pub-id-type="pmid">27521608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palejwala</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Sawhney</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Raecker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Flaxel</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Value of Diagnostic Work-Up in the Evaluation of White Dot Syndromes.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2017</year>
            <month>Jul</month>
            <day>01</day>
            <volume>48</volume>
            <issue>7</issue>
            <fpage>540</fpage>
            <page-range>540-545</page-range>
            <pub-id pub-id-type="pmid">28728181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Mochizuki</surname>
                <given-names>M</given-names>
              </name>
              <collab>members of Scientific Committee of First International Workshop on Ocular Sarcoidosis</collab>
            </person-group>
            <article-title>International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2009</year>
            <season>May-Jun</season>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-9</page-range>
            <pub-id pub-id-type="pmid">19585358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koizumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pozzoni</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence in birdshot chorioretinopathy.</article-title>
            <source>Ophthalmology</source>
            <year>2008</year>
            <month>May</month>
            <volume>115</volume>
            <issue>5</issue>
            <fpage>e15</fpage>
            <page-range>e15-20</page-range>
            <pub-id pub-id-type="pmid">18378316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vance</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Klancnik</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis.</article-title>
            <source>Retina</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>717</fpage>
            <page-range>717-23</page-range>
            <pub-id pub-id-type="pmid">21386760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhaliwal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Maguire</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Flower</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Arribas</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiographic study.</article-title>
            <source>Retina</source>
            <year>1993</year>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-25</page-range>
            <pub-id pub-id-type="pmid">8115733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sieving</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Pugh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Multiple evanescent white dot syndrome. II. Electrophysiology of the photoreceptors during retinal pigment epithelial disease.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1984</year>
            <month>May</month>
            <volume>102</volume>
            <issue>5</issue>
            <fpage>675</fpage>
            <page-range>675-9</page-range>
            <pub-id pub-id-type="pmid">6721750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Puliafito</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>119</volume>
            <issue>9</issue>
            <fpage>1380</fpage>
            <page-range>1380-3</page-range>
            <pub-id pub-id-type="pmid">11545651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levinson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Gonzales</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Birdshot retinochoroidopathy: immunopathogenesis, evaluation, and treatment.</article-title>
            <source>Ophthalmol Clin North Am</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-50, vii</page-range>
            <pub-id pub-id-type="pmid">12434483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Immunosuppression for the Uveitides.</article-title>
            <source>Ophthalmology</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-202</page-range>
            <pub-id pub-id-type="pmid">28942074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akpek</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Tessler</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Joondeph</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of serpiginous choroiditis with alkylating agents.</article-title>
            <source>Ophthalmology</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>109</volume>
            <issue>8</issue>
            <fpage>1506</fpage>
            <page-range>1506-13</page-range>
            <pub-id pub-id-type="pmid">12153803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouvas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Douvali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ntouraki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vergados</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Georgalas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Markomichelakis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.</article-title>
            <source>Retina</source>
            <year>2011</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>871</fpage>
            <page-range>871-9</page-range>
            <pub-id pub-id-type="pmid">21358461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shantha</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Choroidal Neovascularization Associated With Birdshot Chorioretinopathy.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2016</year>
            <month>May</month>
            <day>01</day>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>450</fpage>
            <page-range>450-7</page-range>
            <pub-id pub-id-type="pmid">27183549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy.</article-title>
            <source>Retina</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>545</fpage>
            <page-range>545-9</page-range>
            <pub-id pub-id-type="pmid">12441718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dreyer</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Gass</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1984</year>
            <month>Dec</month>
            <volume>102</volume>
            <issue>12</issue>
            <fpage>1776</fpage>
            <page-range>1776-84</page-range>
            <pub-id pub-id-type="pmid">6508619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krill</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Deutman</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Acute retinal pigment epitheliitus.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1972</year>
            <month>Aug</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-205</page-range>
            <pub-id pub-id-type="pmid">5054230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiore</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iaccheri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Androudi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Papadaki</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Anzaar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brazitikos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis.</article-title>
            <source>Retina</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>994</fpage>
            <page-range>994-1001</page-range>
            <pub-id pub-id-type="pmid">19491729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hangai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fujimoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Features and function of multiple evanescent white dot syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>127</volume>
            <issue>10</issue>
            <fpage>1307</fpage>
            <page-range>1307-13</page-range>
            <pub-id pub-id-type="pmid">19822847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michel</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ekong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baltatzis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Multifocal choroiditis and panuveitis: immunomodulatory therapy.</article-title>
            <source>Ophthalmology</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>378</fpage>
            <page-range>378-83</page-range>
            <pub-id pub-id-type="pmid">11825826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nazari Khanamiri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2013</year>
            <season>May-Jun</season>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-32</page-range>
            <pub-id pub-id-type="pmid">23541041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Hair</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Birdshot retinochoroidopathy: ocular complications and visual impairment.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>140</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-51</page-range>
            <pub-id pub-id-type="pmid">16038650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Choromokos</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1988</year>
            <month>Jun</month>
            <volume>106</volume>
            <issue>6</issue>
            <fpage>796</fpage>
            <page-range>796-800</page-range>
            <pub-id pub-id-type="pmid">3370009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Moradi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>QD</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Burkholder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Ostheimer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and incidence rate of ocular complications in punctate inner choroidopathy.</article-title>
            <source>Retina</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>1666</fpage>
            <page-range>1666-74</page-range>
            <pub-id pub-id-type="pmid">24743642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Isa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>New developments in corticosteroid therapy for uveitis.</article-title>
            <source>Ophthalmologica</source>
            <year>2010</year>
            <volume>224 Suppl 1</volume>
            <fpage>46</fpage>
            <page-range>46-53</page-range>
            <pub-id pub-id-type="pmid">20714181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sallam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Review and update of intraocular therapy in noninfectious uveitis.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>517</fpage>
            <page-range>517-22</page-range>
            <pub-id pub-id-type="pmid">21897242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Albini</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Multiple evanescent white dot syndrome: multimodal imaging and correlation with proposed pathophysiology.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2013</year>
            <month>Nov</month>
            <day>01</day>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>584</fpage>
            <page-range>584-7</page-range>
            <pub-id pub-id-type="pmid">24144177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Acute zonal occult outer retinopathy.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2011</year>
            <season>Jan-Feb</season>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-35</page-range>
            <pub-id pub-id-type="pmid">21056448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wittenberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Kedhar</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.</article-title>
            <source>Ophthalmology</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>113</volume>
            <issue>12</issue>
            <fpage>2310</fpage>
            <page-range>2310-6</page-range>
            <pub-id pub-id-type="pmid">16996607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31354.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>The Eyes Have it: A Rheumatologist's View of Uveitis.</article-title>
            <source>Arthritis Rheumatol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>70</volume>
            <issue>10</issue>
            <fpage>1533</fpage>
            <page-range>1533-1543</page-range>
            <pub-id pub-id-type="pmid">29790291</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
